Brooke Levis, PhD

Director of Epidemiology
Epividian, Inc, Canada

Disclosure(s): Gilead Sciences: Grant/Research Support; Merck & Co.: Grant/Research Support; TheraTechnologies: Grant/Research Support; ViiV Healthcare: Grant/Research Support

Poster(s):

• (P-371) Few differences in persistence and virologic outcomes across age groups among CAB+RPV LA users: Findings from the OPERA Cohort
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET